Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Kymera Therapeutics Inc (KYMR)

Healthcare Biotechnology
103.40 $
-3.4% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Kymera Therapeutics Inc (KYMR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 79.1% of the shares are freely tradable; institutional investors hold 117.6%.

Ownership Structure

Institutional ownership
117.6%
Insiders
2.1%
Float
79.1%
Short % of float
15.6%
Shares Outstanding
82Mio.

Largest Shareholders

Institutions

Institutions KYMR
Name Stake (%) Shares Change (%) Date
FMR Inc 14.22 11,699,950 +31.0 03/31/2026
Baker Bros Advisors LP 10.52 8,657,242 +0.0 03/31/2026
venBio Select Advisor LLC 9.09 7,474,747 +0.0 03/31/2026
Vanguard Group Inc 7.62 6,267,644 +15.6 12/31/2025
T. Rowe Price Associates, Inc. 7.37 6,060,847 -1.6 03/31/2026
Bvf Inc 6.69 5,502,710 +0.0 03/31/2026
T. Rowe Price Investment Management,Inc. 6.64 5,464,997 +652.2 03/31/2026
BlackRock Inc 6.15 5,060,876 +1.1 03/31/2026
Atlas Venture Life Science Advisors, LLC 5.57 4,578,008 -1.8 03/31/2026
Wellington Management Company LLP 4.73 3,889,687 -11.9 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
27. Jul 2026 Rooney Terence Chief Medical Officer Other 38,000 0.00
22. Apr 2026 Bruce Booth Director Sell 5,900 89.96 530,764
22. Apr 2026 Bruce Booth Director Sell 100 90.08 9,008
22. Apr 2026 Jeremy G Chadwick COO Sell 300 90.00 27,000

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?